Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer - Wikidata - wikimedia - TriplyDB

Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer

Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer

http://www.wikidata.org/entity/Q28252307

about

Pelvic radiation disease: Updates on treatment options Chronic radiation proctitis: tricks to prevent and treat The potential of mesenchymal stem cells in the management of radiation enteropathy Chemotherapy-induced cerebrospinal fluid malabsorption in a shunted child: case report and review of the literature Review article: the assessment and management of chronic severe gastrointestinal dysmotility in adults Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French S Radiation enteropathy--pathogenesis, treatment and prevention Guidance: The practical management of the gastrointestinal symptoms of pelvic radiation disease Radiation-induced small bowel disease: latest developments and clinical guidance Typhlitis (neutropenic enterocolitis) in patients with acute leukemia: a review.Endoscopy in neutropenic and/or thrombocytopenic patients.[Abdominal spasms, meteorism, diarrhea: fructose intolerance, lactose intolerance or IBS?].Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy.Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers Acta Oncologica Lecture. Gastrointestinal consequences of cancer treatment and the wider context: a bad gut feeling.A systematic review of the nutritional consequences of esophagectomy Gastroenterologist and nurse management of symptoms after pelvic radiotherapy for cancer: an economic evaluation of a clinical randomized controlled trial (the ORBIT study)Targeting precision medicine toxicity: recent developments.Systematic review: anal and rectal changes after radiotherapy for prostate cancer.Trans-sectoral care in patients with colorectal cancer: Protocol of the randomized controlled multi-center trial Supportive Cancer Care Networkers (SCAN)Baseline immune biomarkers as predictors of MBSR(BC) treatment success in off-treatment breast cancer patients Pelvic radiation therapy: Between delight and disaster.Is referral of postsurgical colorectal cancer survivors to cardiac rehabilitation feasible and acceptable? A pragmatic pilot randomised controlled trial with embedded qualitative study.Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial Radioprotective potential of histamine on rat small intestine and uterus.Intestinal permeability to iohexol as an in vivo marker of chemotherapy-induced gastrointestinal toxicity in Sprague-Dawley rats.CRIB--the use of cardiac rehabilitation services to aid the recovery of patients with bowel cancer: a pilot randomised controlled trial (RCT) with embedded feasibility study.A cure for post-radiation proctitis?Mucosa-associated lymphoid tissue lymphoma with unusual 18F-FDG hypermetabolism arising at the colorectal anastomosis.Managing the consequences of cancer treatment and the English National Cancer Survivorship Initiative.Anal cancer: are we making progress?Management of radiation-induced rectal bleeding.Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis.Patients' experiences of receiving chemotherapy in outpatient clinic and/or onboard a unique nurse-led mobile chemotherapy unit: a qualitative study.Managing gastrointestinal symptoms after cancer treatment: a practical approach for gastroenterologists.Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy.Rifaximin for Pertuzumab-Related GI Toxicities.Systematic Review: The Impact of Cancer Treatment on the Gut and Vaginal Microbiome in Women With a Gynecological Malignancy.Butyric acid - a well-known molecule revisited.Use of computed tomography abdomen and pelvis for investigation of febrile neutropenia in adult haematology patients.

P2860

Q26775088-75DFDAA4-10FA-4F64-9006-BC904888CCC6 Q26801205-F402DF2D-44AA-4127-96EC-FB33F791338A Q26801540-F42F42EC-3FE0-4706-953A-3283A03AE052 Q26825090-BA17583F-77BA-4391-AD43-E9FA1F999A72 Q27030666-7BDA8F86-A65B-4C21-8610-949351E6F085 Q27320711-491CCF90-C945-4822-99CC-7D5BE345D35A Q28237189-DC6B0C5D-D591-458B-8206-9F52A8AC596E Q28255314-470B5EF6-E10D-4E7D-8370-29D0FCFA504A Q28304957-411A835F-6183-4EC8-B371-58F4EC4FBC9E Q30239073-CE91F7D8-090E-4E44-B914-02E45A1C3C1D Q33428440-9368F06A-9BCE-4B3B-838A-89AED7A0C3A2 Q33456602-92E22741-CBD2-480E-8B0A-1618F40216B2 Q33457440-E1186D06-BBEB-4C57-B0C2-F50C65F58AF2 Q33459118-EE1C4761-FC55-461A-9206-ED79E9FBC23C Q33460604-502A73FD-F3A2-49DE-9CF8-8546E2ECEF6E Q33618186-E19C5643-1F5F-458D-9BB2-EE913C2DB614 Q33638354-90DFAD14-437B-496C-A5BC-718EE4CDD653 Q35019470-03B475C1-C474-40CC-93DE-D9262D8BFC61 Q35024218-235737B7-D937-47FD-9684-3A02E39B8616 Q35875582-50E5784F-3AED-433B-9155-F0F7ADB18101 Q36159062-4F5AF606-61A0-47E2-A4BF-69ED60E2206B Q36329095-72232C7B-D6BA-433D-B96D-CF3DF9FA2A98 Q36472180-84F90351-EB4C-4D75-B660-A752C6D61FBB Q36534810-1B1EFE58-A504-477C-8C4B-909B04D12375 Q36596572-34DC19A1-FC50-4FDF-AB05-8A833B2A003E Q37293285-0D6C6F73-7CE1-4E0D-B2EA-876CBDF73CB0 Q37598062-6F58FC12-6C12-450C-9EC7-205B5B0329B3 Q37602296-7D74B71C-CE82-4A15-A822-159027519051 Q37624527-4F561611-B5FD-4E79-9C52-5C645487D869 Q38067106-A6B645C8-DBD4-4EB7-BF6E-114B7F5F5CE8 Q38078283-521D3350-8DA3-4C51-BEDF-E365B2E6CB87 Q38150246-859AB66B-F13C-4A74-B592-717F1ED9783D Q38357630-892C8E90-FF15-4079-BC1F-397A5553AB8C Q38565654-05A5A22E-E081-4A26-AFA6-17FF1D13C53E Q38609169-181F1DB8-2817-4ED0-9A23-EC089C2B6DA9 Q38973323-47C664AD-D3F5-4C5B-8A7E-2A5BAFB4B66F Q39150776-952B0BC7-F85F-41CF-AFE4-CCA341242BE9 Q39357618-275222E0-06BC-498F-8F8A-325355570900 Q39431579-9D4A0DF1-E772-4FCC-9368-5C338E3F61E2 Q40081185-F53442DD-6937-4017-A870-F732129DA76F

P2860

Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer

http://www.wikidata.org/entity/Q28252307

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Practice guidance on the manag ...... result of treatment for cancer

@ast

Practice guidance on the manag ...... result of treatment for cancer

@en

Practice guidance on the manag ...... result of treatment for cancer

@nl

type

label

Practice guidance on the manag ...... result of treatment for cancer

@ast

Practice guidance on the manag ...... result of treatment for cancer

@en

Practice guidance on the manag ...... result of treatment for cancer

@nl

prefLabel

Practice guidance on the manag ...... result of treatment for cancer

@ast

Practice guidance on the manag ...... result of treatment for cancer

@en

Practice guidance on the manag ...... result of treatment for cancer

@nl

P1433

Q28252307-745AE1A6-2CA1-40BD-852C-51B37EFB9BD4

P1476

Q28252307-6EECB656-63AD-4EA4-8272-0452CEBA1F82

P2093

Q28252307-15BEF045-3DC8-4021-A634-8221D1DE1F2D

Q28252307-B8E3D08D-642F-4E21-947F-E9D3B92EC422

Q28252307-D1E74DF1-B928-419D-B88A-E5DD3FAC4123

Q28252307-E863118B-EF6E-46F4-BD3F-F47FEFF30C45

Q28252307-FF7F5BA9-8D18-4B9B-BC1A-B537D2F371AF

P2860

Q28252307-00C29611-E5B4-4FED-8FA1-1ED158379EA1

Q28252307-0A74AF44-80D9-4BC9-BBDB-004A89A740DF

Q28252307-0C932EFB-1C31-45E8-9125-E8461772BBAA

Q28252307-0EAD278D-D6C7-4BB9-AFED-2DD78EF593E4

Q28252307-10B8CD0D-BF77-49DD-A39F-DF552ADB1FB4

Q28252307-1250220A-BACC-480E-8058-172B5EBD90B5

Q28252307-16917BDF-503F-42E5-99C4-C39627B1289C

Q28252307-1823BEFB-DAC8-496C-89C1-EA6CE31C97A9

Q28252307-18E44AB1-1B41-4E8C-9F2F-4805751F98F0

Q28252307-21088A5C-7D8A-4898-9AAF-8633627587AA

P304

Q28252307-9875B0BD-5539-4A86-8B12-F56E73A91B1A

P31

Q28252307-D1E0309C-B7C2-434C-A7AA-223FDD6AA953

P3181

Q28252307-6F66A416-0EFD-4ABB-91E5-C1F30F130942

P356

Q28252307-DBD5B21D-D1A6-4489-A953-D1FC1B237902

P407

Q28252307-112728A8-374C-404E-BCE7-8673CB645995

P433

Q28252307-B148463E-391B-4252-BC5F-717DA00B4FC8

P478

Q28252307-1729298A-5153-4F71-BB08-16CAD9B2CB9B

P577

Q28252307-B03A0EC8-E2D3-4FE1-AF07-CAE977F33AE5

P5875

Q28252307-80C4BBD0-F763-4C75-B367-849DF06C4598

P698

Q28252307-A30EE164-2074-475C-AD7E-DE2799852B75

P932

Q28252307-8A02F4B8-E167-42B4-8A49-79ECB2DBB9EE

P3181

P356

GUTJNL-2011-300563

P1433

P1476

Practice guidance on the manag ...... result of treatment for cancer

@en

P2093

Catherine Gillespie

http://www.w3.org/2001/XMLSchema#string

Edwin Swarbrick

http://www.w3.org/2001/XMLSchema#string

H Jervoise N Andreyev

http://www.w3.org/2001/XMLSchema#string

Susan E Davidson

http://www.w3.org/2001/XMLSchema#string

William H Allum

http://www.w3.org/2001/XMLSchema#string

P2860

Hyperbaric oxygen therapy for late radiation tissue injury

Non surgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvis

Argon plasma coagulation for radiation proctitis

Treatment of radiation proctitis with argon plasma coagulation.

Efficacy and complications of argon plasma coagulation for hematochezia related to radiation proctopathy.

Endoscopic therapy for radiation proctitis-induced hemorrhage in patients with prostatic carcinoma using argon plasma coagulator application.

Argon plasma coagulation as first-line treatment for chronic radiation proctopathy.

Effective use of argon plasma coagulation in the treatment of severe radiation proctitis.

Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.

Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial.

P304

179-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2620627

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/GUTJNL-2011-300563

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51773521

http://www.w3.org/2001/XMLSchema#string

P698

22057051

http://www.w3.org/2001/XMLSchema#string

P932

3245898

http://www.w3.org/2001/XMLSchema#string